Safety outcomes of anti-platelet therapy post coronary artery bypass graft surgery: A systematic review and network meta-analysis of randomized control trials

CONCLUSION: No significant difference was found between monotherapy or dual-antiplatelet therapy for the major bleeding risk safety outcome, however DAPT was found to have a significantly higher rate of minor bleeding complications post-CABG. DAPT should be considered as the antiplatelet modality of choice post-CABG.PMID:36803180 | DOI:10.1177/02676591231159513

Source: Perfusion - February 21, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Syed U Hasan Alina Pervez Arshad A Shah Syed DA Shah Muhammad Aslam Anosha Arshad Amna S Rajput M Mujeeb Zubair Source Type: research